← Eichor
Study identifier: NCT07516964 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Condition: Nephrotic Syndrome With Edema (Diagnosis) · Minimal Change Nephrotic Syndrome · Focal Segmental Glomerulosclerosis (FSGS)  ·  Sponsor: Meyer Children's Hospital IRCCS

PhaseNA
Planned participants50
Who can joinAll sexes, 0 Years to 99 Years
Healthy volunteersNo

About this study

Nephrotic syndrome is a kidney condition that mainly affects children and is characterized by high levels of protein in the urine, low levels of protein in the blood, and swelling. While many children respond well to steroid treatment, a large proportion experience relapses or become dependent on therapy. In some cases, the disease does not respond to standard treatments and may progress to chronic kidney disease. Recent research suggests that, in addition to genetic factors, immune system mechanisms may play a key role in the development and progression of nephrotic syndrome. In particular, some patients produce autoantibodies against nephrin, an essential protein of the kidney filtration barrier. These autoantibodies may be associated with disease activity and treatment response. The aim of this study is to investigate the presence of anti-nephrin autoantibodies in children with nephrotic syndrome and to better understand their role in disease mechanisms and clinical outcomes.The study will also explore the presence of other autoantibodies targeting components of the glomerular filtration barrier. The study will use advanced laboratory techniques, including blood tests and detailed analysis of kidney biopsy samples, to identify these antibodies and their relationship with kidney structure and function. By integrating laboratory findings with clinical data, this study aims to improve the understanding of nephrotic syndrome and support the development of more personalized …

This description comes directly from the study's public registry record.

Talk to the study team

Paola Romagnani, MD, PhD  ·  +39 0555662563  ·  paola.romagnani@meyer.it

Always discuss trial participation with your own doctor first.

Locations (14)

Mayo ClinicRochester, Minnesota, United StatesNot Yet Recruiting
Ludwig-Maximilians UniversitatMünchen, GermanyNot Yet Recruiting
Ospedale Santa Maria AnnunziataBagno a Ripoli, Firenze, ItalyNot Yet Recruiting
Meyer Children's Hospital IRCCSFlorence, FIRENZE, ItalyRecruiting
IRCCS Azienda Ospedaliero - UniversitariaBologna, ItalyNot Yet Recruiting
Azienda Ospedaliero Universitaria CareggiFlorence, ItalyNot Yet Recruiting
Ospedale S. Giovanni di DioFlorence, ItalyNot Yet Recruiting
IRCCS Istituto Giannina GasliniGenova, ItalyNot Yet Recruiting
Azienda Ospedaliero-Universitaria di ParmaParma, ItalyNot Yet Recruiting
Azienda Ospedaliero Universitaria PisanaPisa, ItalyNot Yet Recruiting
Ospedale Santo StefanoPrato, ItalyNot Yet Recruiting
Azienda USL - IRCCSReggio Emilia, ItalyNot Yet Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07516964